Search clinical trials for: Accu-Chek® Insight Insulin Pump

Total 31 results

Hoffmann-La Roche

Completed

European, Open-label, Prospective, Multinational, Multicenter Study in Adult Subjects With Type 1 or Type 2 Diabetes Previously on MDI or CSII Therapy. Subjects Home Setting is Considered Routine Practice.

Type 2 Diabetes, Type 1 Diabetes

Austria, United Kingdom
Hoffmann-La Roche
Roche Diabetes Care GmbH

Completed

Comparing Continuous Subcutaneous Insulin Infusion With Multiple Daily Injections to Reach HbA1c Targets in Children and Adolescents With Type 1 Diabetes (Insight Kids)

Diabetes Mellitus Type 1

Germany, Austria, United Kingdom
Hoffmann-La Roche

Completed

A Monocenter, Open-Label Glucose Clamp Study Examining the Metabolic Effect of Insulin Infusion Intervals for Basal Insulin Infusion in Patients With Type I Diabetes

Diabetes Mellitus Type 1

Germany
Hoffmann-La Roche

Completed

Comparison of Basal (Fasting) Glycemic Control in Type 1 Diabetic Patients With CSII Achieved by the Circadian Slide Ruler Scale or Flat Basal Rate

Diabetes Mellitus Type 1

Germany
Ascensia Diabetes Care

Completed

Evaluation of Blood Glucose Meter Systems

Diabetes

United States
Hoffmann-La Roche

Completed

Accu-Chek® CONNECT at School (CATS) Pediatric Study (CATS)

Diabetes Mellitus, Type 1

United States
Shanghai 6th People's Hospital

Unknown

Effect of Paired Testing to Poorly Controlled Chinese Diabetes on Glycemic Control and Self Care

Diabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1

China
Institut für Diabetes-Technologie Forschungs- und...
Sanofi

Completed

Assessment of Blood Glucose Monitoring Systems

Diabetes

Germany
Becton, Dickinson and Company

Completed

Study on the Effects on Blood Glucose Following Intradermal and Subcutaneous Dosing of Insulin in Diabetic Patients

Diabetes

Germany
Institut de Recherches Cliniques de Montreal
Réseau de recherche en santé cardiométabolique, diabète et obésité

Completed

Closed-loop Control of Glucose Levels (Artificial Pancreas) for 24 Hours in Adults With Type 2 Diabetes Under Intensive Insulin Therapy

Type 2 Diabetes

Canada
Becton, Dickinson and Company

Completed

Pharmacokinetics/Dynamics of Basal (Continuous) Insulin Infusion Administered Either Intradermally or Subcutaneously

Diabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1

Germany
Ascensia Diabetes Care

Completed

Comparison Evaluation of Blood Glucose Meter Systems

Diabetes

United States
University of Colorado, Denver

Completed

Improved Glycemic Control in Adult Subjects With Type 1 Diabetes on MDI Using Insulin Guidance Software

Diabetes

United States
Ascensia Diabetes Care

Completed

Comparison Evaluation of Blood Glucose Meter Systems in a Clinical Setting

Diabetes

United States
Abbott Diabetes Care

Completed

Ease of Use of New Blood Glucose Meter With In-built Insulin Calculator at Home Study (IHUT)

Diabetes Mellitus

United Kingdom
Hoffmann-La Roche

Completed

Participant-Reported Outcomes With the Accu-Chek® Solo Micropump System (PRO Solo)

Diabetes Mellitus, Type 1

Austria, Germany, Poland, United Kingdom
Institut de Recherches Cliniques de Montreal

Completed

Safety of Overestimation of a Meal Insulin Bolus in the Context of Dual-hormone Closed-loop Operation - Part 2

Type 1 Diabetes

Canada
Institut de Recherches Cliniques de Montreal

Completed

Safety of Overestimation of a Meal Insulin Bolus in the Context of Dual-hormone Closed-loop Operation

Type 1 Diabetes

Canada
Institut für Diabetes-Technologie Forschungs- und...
Ascensia Diabetes Care

Completed

User Performance Evaluation of Contour® Next One, Accu-Chek® Aviva Connect, FreeStyle Freedom Lite, OneTouch® Verio and GlucoMen® Areo Blood Glucose Monitoring Systems Following ISO 15197:2013

Diabetes Mellitus

Germany
Jesús Moreno Fernández
University of Castilla-La Mancha

Completed

Faster Aspart on Insulin-pump Treated T1DM Patients (realFACI)

Type 1 Diabetes

Spain
Arkansas Children's Hospital Research Institute

Completed

Preservation of Pancreatic Beta Cell Function Through Insulin Pump Therapy (ktpump)

Diabetes Mellitus

United States
Sheffield Teaching Hospitals NHS Foundation Trust
King's College Hospital NHS Trust; Cambridge University Hospitals NHS Foundation... and other collaborators

Completed

The REPOSE (Relative Effectiveness of Pumps Over MDI and Structured Education) Trial (REPOSE)

Type 1 Diabetes

United Kingdom
Ypsomed AG
Diabetes Center Berne Research AG

Completed

YpsoPump Occlusion Detection Algorithm: Collection of Real-world Data for In-silico Evaluation of a New Software Algorithm to Refine Occlusion Detection in Subjects With Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion

Diabetes Mellitus, Type 1

Germany, Switzerland
Peking Union Medical College Hospital

Unknown

Preliminary Exploration on the Operational Standards of Insulin Pump Installation in Diabetes Clinic in China

Type 2 Diabetes Mellitus | Type 1 Diabetes Mellitus | Gestational Diabetes Mellitus | Pancreatogenic Diabetes Mellitus | Pregestational Diabetes Mellitus | Diabetes Patients in Perioperative Period

China
Medtronic Diabetes

Completed

User Evaluation of the MiniMed 640G Insulin Pump

Type 1 Diabetes | Type 2 Diabetes

United Kingdom, Australia
Medtronic Diabetes

Completed

OpT2mise Glucose Control in Type 2 Diabetes Mellitus (DM) With Insulin Pump Therapy (OpT2mise)

Diabetes Mellitus, Type 2

United States, France, Germany, Austria, Canada, Hungary, Israel, Italy, Macedonia, The Former Yugoslav Republic of, Netherlands, Serbia, South Africa, Spain
Texas Diabetes & Endocrinology, P.A.

Completed

FIasp® vs. Novolog® in Type 1 Diabetics Using 670G Medtronic Pump

Type 1 Diabetes Mellitus

United States
Medtronic Diabetes

Completed

Outpatient Study to Evaluate Safety and Effectiveness of the Low Glucose Suspend Feature (ASPIRE)

Type 1 Diabetes

United States
Institut de Recherches Cliniques de Montreal
Juvenile Diabetes Research Foundation

Withdrawn

Closed-loop Control of Postprandial Glucose Levels in Children and Adults With Type 1 Diabetes

Type 1 Diabetes

Canada
Mitsubishi Tanabe Pharma Corporation

Completed

A Phase III, Multicentre, Double-Blind, Placebo-Controlled Withdrawal Study in Patients With Hyperphosphatemia

Chronic Kidney Disease | Hyperphosphatemia

France, Poland, United Kingdom, Spain, South Africa, Australia, Czech Republic, Germany, Hungary, Italy, Austria
Medtronic Corporate Technologies and New Ventures

Completed

Safety and Efficacy Study to Compare Continuous Infusion of Interferon With Standard of Care for Chronic Hepatitis C (COPE-HCV)

Hepatitis C

United States

3

Subscribe